American College of Clinical Pharmacy
      Search      Cart

ACCP Report - August 2018

Webb Retires, Leaving a Lasting Legacy at ACCP

C. Edwin Webb, Pharm.D., MPH

C. Edwin Webb, Pharm.D., MPH, longtime director of Government and Professional Affairs and ACCP associate executive director, retired July 31 after serving in a part-time role since January 2018. He will continue to serve the College’s Board of Regents and executive staff as a consultant.

Webb joined ACCP in April 2000 as its inaugural director of Government and Professional Affairs and shortly thereafter established a new College office in Washington, D.C. Before coming to ACCP, he worked in professional affairs at the American Pharmaceutical Association (now the American Pharmacists Association) and in professional/government affairs at the American Association of Colleges of Pharmacy (AACP).

A consummate association professional, Webb hit the ground running at ACCP, building relationships to educate key stakeholders, expand ACCP’s influence, and increase the visibility of clinical pharmacy in the national political, policy, and interprofessional arenas. He led advocacy efforts, together with staff of other national pharmacy associations, through the Provider Status and the Leadership for Medication Management coalitions to seek changes to Medicare Part B for the coverage of pharmacists’ patient care services. In 2001–2009, these activities were directed toward the Medicare Modernization Act of 2003 (establishing the Part D drug benefit and MTM provisions) and subsequently the Affordable Care Act (PPACA) in 2010 (“Obamacare”). Webb worked with staff from the American Society of Health-System Pharmacists and faculty at the Virginia Commonwealth University to develop the ACCP/ASHP/VCU Pharmacy Healthcare Policy Fellow program, now in its 11th year. He was instrumental in the work of the multi-organizational Council on Credentialing in Pharmacy to provide guidance, standards, and promotion of the profession’s credentialing, accreditation, and certification efforts. Webb also led ACCP’s collaboration with AACP in 2011–2012 to establish the Institute of Medicine (now the National Academy of Medicine) Fellowship in Pharmacy. Most recently, he was integral in developing ACCP’s Standards of Practice for Clinical Pharmacists and the policy constructs, practice standards, and desired deliverables contained in the RFA (request for application) for the $2.4 million ACCP grant to study the implementation of comprehensive medication management in primary care medical practices. He also led the expansion of ACCP’s Washington, D.C., staff in 2006–2018.

ACCP Establishes the C. Edwin Webb Professional Advocacy Award

Throughout his professional career, Webb has served as a valued leader, mentor, and friend to countless pharmacist colleagues, including the executive and volunteer leadership of ACCP and other pharmacy associations and ACCP members, students, and trainees. In recognition of his commitment, vision, and many contributions to the advancement of clinical pharmacy, the Board of Regents has established the C. Edwin Webb Professional Advocacy Award, which will issue its first call for nominations in 2018–2019 (see the Call for Nominations elsewhere in this issue of the ACCP Report). The award will recognize an ACCP member who:

  • Has made outstanding contributions to the visibility and value of clinical pharmacy in national political, policy, intraprofessional, and/or interprofessional arenas;
  • Has assembled a record of mentoring others who have gone on to assume a health professions and/or health policy leadership role; and
  • Is recognized as an ambassador for clinical pharmacy both within and outside the profession.

Asked to provide perspective on his career with ACCP, Webb commented:

Being a member of the senior executive staff of ACCP for almost 2 decades has been the ultimate professional opportunity – and experience – of my career. The core values, mission, and purpose of the College and its members, from the founding in 1979, have made representing and articulating the practice, research, and teaching activities of clinical pharmacists the simplest and still most profound pharmacy advocacy message in Washington, D.C. – “the patient-centered, team-based practice of clinical pharmacists that optimizes medication use.” I am forever grateful to Drs. Elenbaas and Maddux, and the many Boards of Regents they have led, for their absolute commitment to the importance of this work and to their faith in me and our D.C. staff to execute the College’s advocacy agenda. The work is incremental and never-ending. But it is succeeding in its purpose. I have been blessed to be a part of it.